Shingles vaccine study for people with rheumatic diseases
Treatments studied
Part of Bones, joints & muscles, Brain & nervous system, Heart & circulation, Immune system & allergy, Infections, Skin clinical trials.
This study offers the Shingrix shingles vaccine for free to adults with inflammatory rheumatic diseases. It compares how well the vaccine works in people taking immune-suppressing drugs versus those not taking them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have an inflammatory rheumatic disease (like rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis).
- You are regularly seen at the rheumatology department at Skåne University Hospital in Lund or Malmö, Sweden.
- You are either on certain arthritis medications (DMARDs) or not on them (except for up to 5 mg of prednisolone daily).
- If you are a woman who could become pregnant, you agree to use reliable birth control.
- You have not already received the Shingrix vaccine.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether Shingrix (a shingles vaccine) is safe and works well in adults with rheumatic or immune-related conditions. It compares Shingrix to a placebo (inactive shot) to see how well it prevents shingles and affects immune symptoms.
This study tests the recombinant shingles vaccine in adults with autoimmune rheumatic diseases who are on certain mild medications. It aims to see if the vaccine is safe and effective for them.
This study looks at how well the shingles vaccine works in people with autoimmune inflammatory diseases. Researchers want to make sure the vaccine provides good protection for patients whose immune systems are affected by their condition or treatment.
This study tests a new shingles vaccine in people with psoriasis or myelofibrosis, some of whom take immune-modifying medications. Researchers want to understand how well the vaccine works and how the immune system responds in these groups.
This trial tests a new shingles vaccine in healthy adults aged 50 to 65. Shingles can cause a painful rash, and the vaccine aims to prevent it.
This study tests how well the shingles vaccine (Shingrix) works in people with lupus who take immune-suppressing medications. Researchers want to understand if the vaccine provides good protection in lupus patients, since their immune systems work differently.
Hear when a new Systemic Vasculitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.